Darwin Wealth Management
XBIO icon

Darwin Wealth Management’s Xenetic Biosciences XBIO Stock Holding History

Darwin Wealth Management’s Portfolio XBIO Stock Details XBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4 Hold
2
– – ﹤0.01% 1187
2026
Q2 		$5 Hold
2
– – ﹤0.01% 761
2026
Q1 		$5 Hold
2
– – ﹤0.01% 601
2025
Q4 		$4 Hold
2
– – ﹤0.01% 658
2025
Q3 		$6 Hold
2
– – ﹤0.01% 604
2025
Q2 		$7 Hold
2
– – ﹤0.01% 605
2025
Q1 		$7 Hold
2
– – ﹤0.01% 637
2024
Q4 		$7 Hold
2
– – ﹤0.01% 637
2024
Q3 		$9 Buy
+2
New +$8 ﹤0.01% 645
2020
Q2 		– Sell
-1
Closed – – 804
2020
Q1 		$0 Buy
+1
New +$12 ﹤0.01% 862

Other funds holding XBIO

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $273B AUM 15.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Darwin Wealth Management's XBIO Position: Q3 2026 in Review

Darwin Wealth Management held its Xenetic Biosciences (XBIO) position steady in Q3 2026 at 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #1187.

Darwin Wealth Management first reported a position in XBIO in Q1 2020 and has held it in 10 quarters since. The position peaked at $9 in Q3 2024. 12 funds tracked by Wall St. Rank hold XBIO as of Q3 2026.

  • Darwin Wealth Management held 2 shares of Xenetic Biosciences worth $4 as of Q3 2026.
  • Darwin Wealth Management left its Xenetic Biosciences share count unchanged in Q3 2026.
  • Xenetic Biosciences made up ﹤0.01% of Darwin Wealth Management's portfolio in Q3 2026, its #1187 holding.
  • Darwin Wealth Management first reported a position in Xenetic Biosciences in Q1 2020 and has held it in 10 quarters since.
  • Darwin Wealth Management's Xenetic Biosciences position peaked at $9 in Q3 2024.
  • 12 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q3 2026.

Based on Darwin Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.